FP0392, Confidence, Glucosamine Plus, with White Willow Bark & Boswella, 90 Extended Release Tablets, UPC# 8 10891 02253 7

FDA recall notice · announced August 22, 2018 · Confidence Inc./confidence U.s.a

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

Reason for recall

Product contains undeclared ingredients, Hydroxypropyl Methylcellulose (HPMC), Titanium Dioxide, Polyethylene Glycol 400 and 800 (PEG), Triacetin

Notes

Distribution: Nationwide
Lot/code information: Lot# 010216 Lot# 070816 Lot# 090117 Lot# 100817
Quantity: 5,650 bottles in US distribution (total for all products)
Status: Terminated
Products in this recall event:
- FP0692, Confidence, Prenatal Multi-V + DHA, 90 tablets per bottle, UPC# 8 10891 02056 4 (F-1815-2018)
- FP0391 Confidence, Glucosamine Plus, With Hyaluronic Acid + Curcumin & Boswellia, 60 Extended Release Tablets, UPC: 8 92483 00106 9 (F-1816-2018)
- FP0292 Confidence Nitro-Cross 60s, UPC# 8 92483 00155 7 (F-1814-2018)
- FP0392, Confidence, Glucosamine Plus, with White Willow Bark & Boswella, 90 Extended Release Tablets, UPC# 8 10891 02253 7 (F-1813-2018)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.